Across TCGA pan-cancer cohorts, MIR890 RNA is linked to patient survival in 2 of 34 cancer types, making it a survival-associated MIR890 data layer compared with 3 for mutation status.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher MIR890 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR890 expression acts as an unfavorable survival marker.

UCEC and SKCM are the cancer types where MIR890 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Tertile	All	0.802	0.928	.002	54	view →
SKCM	OS	Tertile	All	0.233	0.787	.004	36	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: MIR890 tumor-vs-normal RNA expression · all MIR890 data types